Role of peripheral nerve stimulation in treating chronic neuropathic pain: an international focused survey of pain medicine experts

被引:13
作者
Li, Alice Huai-Yu [1 ]
Bhatia, Anuj [2 ]
Gulati, Amit [3 ]
Ottestad, Einar [4 ]
机构
[1] Stanford Univ, Dept Anesthesia, Stanford, CA USA
[2] Univ Toronto, Dept Anesthesia & Pain Med, Toronto, ON, Canada
[3] Mem Sloan Kettering Canc Ctr, Dept Anesthesiol & Crit Care, New York, NY USA
[4] Stanford Univ, Anesthesiol & Pain Med, Sch Med, Palo Alto, CA USA
关键词
pain management; peripheral nerve injuries; spinal cord stimulation; LOW-BACK-PAIN; MANAGEMENT; ALGORITHM; BURDEN; GUIDELINES;
D O I
10.1136/rapm-2022-104073
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Interventional pain management (IPM) options for refractory neuropathic pain (NP) have recently increased with availability of peripheral nerve stimulation (PNS) equipment and expertise. Given a lack of high-quality evidence and guidelines on this topic, we sought to understand the perception of physicians with expertise in treating NP regarding IPM and the role of PNS. We emailed a survey in March 2022 to international NP experts including pain medicine physicians, researchers, and leaders of 11 professional pain societies. No representatives from vendors of PNS systems were included in the design of the survey nor as respondents. Among 24 respondents (67% of those contacted), the distal common peroneal, tibial, and sural nerves were most frequently targeted (60%) with PNS. Persistent postsurgical pain of more than 3 months was the most common indication for PNS (84%). The aggregate NP treatment algorithm in order of median rank was non-opioid medications as first line, IPM including epidural/perineural steroid injections tied with transcutaneous electrical nerve stimulation as second line, pulsed radiofrequency (RF) tied with RF ablation/denervation as third line, temporary then permanent PNS as fourth line, followed by spinal cord stimulation, opioids, cryoablation, botulinum, peripheral nerve field stimulation, intrathecal targeted drug delivery, and others. Before offering PNS, 12 respondents (50%) indicated their preference for trialing non-neuromodulation treatments for 1-3 months. Twenty-two respondents (92%) agreed PNS should be offered early in the treatment of neuropathic pain. The most common barriers to PNS use were cost, lack of high-quality evidence in support of its use, lack of exposure to PNS in training programs, and lack of familiarity with the use of ultrasound guidance. PNS appears to have an increasing role in the treatment of NP but more research is needed on the outcomes of PNS to elucidate its role.
引用
收藏
页码:312 / 318
页数:7
相关论文
共 50 条
[21]   Effectiveness of Neurostimulation Technologies for the Management of Chronic Pain: A Systematic Review [J].
Hofmeister, Mark ;
Memedovich, Ally ;
Brown, Sage ;
Saini, Manik ;
Dowsett, Laura E. ;
Lorenzetti, Diane L. ;
McCarron, Tamara L. ;
MacKean, Gail ;
Clement, Fiona .
NEUROMODULATION, 2020, 23 (02) :150-157
[22]   A Feasibility Study of Percutaneous Peripheral Nerve Stimulation for the Treatment of Postoperative Pain Following Total Knee Arthroplasty [J].
Ilfeld, Brian M. ;
Ball, Scott T. ;
Gabriel, Rodney A. ;
Sztain, Jacklynn F. ;
Monahan, Amanda M. ;
Abramson, Wendy B. ;
Khatibi, Bahareh ;
Said, Engy T. ;
Parekh, Jesal ;
Grant, Stuart A. ;
Wongsarnpigoon, Amorn ;
Boggs, Joseph W. .
NEUROMODULATION, 2019, 22 (05) :653-660
[23]  
Jensen Troels S, 2007, Curr Opin Support Palliat Care, V1, P126, DOI 10.1097/SPC.0b013e3282eeb45f
[24]   Neuropathic Pain and Pharmacological Treatment [J].
Jongen, Joost L. M. ;
Hans, Guy ;
Benzon, Honorio T. ;
Huygen, Frank ;
Hartrick, Craig T. .
PAIN PRACTICE, 2014, 14 (03) :283-295
[25]   Effect of Radiofrequency Denervation on Pain Intensity Among Patients With Chronic Low Back Pain The Mint Randomized Clinical Trials [J].
Juch, Johan N. S. ;
Maas, Esther T. ;
Ostelo, RaymondW. J. G. ;
Groeneweg, J. George ;
Kallewaard, Jan-Willem ;
Koes, Bartw. ;
Verhagen, Arianne P. ;
van Dongen, Johanna M. ;
Huygen, Frank J. P. M. ;
van Tulder, MauritsW. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (01) :68-81
[26]   The Dorsal Root Ganglion in Chronic Pain and as a Target for Neuromodulation: A Review [J].
Krames, Elliot S. .
NEUROMODULATION, 2015, 18 (01) :24-32
[27]   Radiofrequency ablation for chronic low back pain: A systematic review of randomized controlled trials [J].
Leggett, Laura E. ;
Soril, Lesley J. J. ;
Lorenzetti, Diane L. ;
Noseworthy, Tom ;
Steadman, Rodney ;
Tiwana, Simrandeep ;
Clement, Fiona .
PAIN RESEARCH & MANAGEMENT, 2014, 19 (05) :E146-E153
[28]   A burden of illness study for neuropathic pain in Europe [J].
Liedgens, Hiltrud ;
Obradovic, Marko ;
De Courcy, Jonathan ;
Holbrook, Timothy ;
Jakubanis, Rafal .
CLINICOECONOMICS AND OUTCOMES RESEARCH, 2016, 8 :113-126
[29]  
Magrinelli Francesca, 2013, Pract Neurol, V13, P292, DOI 10.1136/practneurol-2013-000536
[30]  
Manchikanti Laxmaiah, 2003, Pain Physician, V6, P485